**Stage 1: Initial Presentation**

**Chief Complaint:**
A 48-year-old female presents with malaise for two weeks and intractable nausea and vomiting for the past two days.

**History of Present Illness:**
The patient was brought to the emergency department by ambulance due to worsening malaise and recurrent mild nausea and vomiting over the past two weeks, with symptoms exacerbating the night before admission. She denies abdominal pain, fevers, chills, or chest pain.

**Past Medical History:**
- Diabetes mellitus diagnosed at age 20; type unclear, managed with insulin.

**Medications:**
- Insulin glargine (Lantus) 24 units daily.
- Atorvastatin.

**Social History:**
- No recent travel.
- No known sick contacts.
- Denies tobacco, alcohol, and illicit drug use.

**Vital Signs:**
- Temperature: 36°C
- Heart Rate: 89 beats per minute
- Blood Pressure: 118/54 mmHg
- Respiratory Rate: 19 breaths per minute
- Oxygen Saturation: 99% on room air
- Body Mass Index (BMI): 28 kg/m²

**Physical Examination:**

- **General:** Alert and oriented to person, place, time, and situation.
- **HEENT:** Icteric sclerae noted.
- **Cardiovascular:** Regular rate and rhythm; no murmurs, rubs, or gallops.
- **Respiratory:** Lungs clear to auscultation bilaterally.
- **Abdominal:** Distended abdomen; soft and non-tender on palpation; dullness to percussion; positive fluid wave indicating ascites.
- **Neurological:** No asterixis observed.
- **Extremities/Skin:** Bilateral +2 pitting edema in lower extremities.

---

**Stage 2: Additional Diagnostic Information**

**Laboratory Data:**

- **Complete Blood Count:**
  - White Blood Cells: 7×10³/μL
  - Hemoglobin: 16.1g/dL
  - Platelets: 182×10³/μL

- **Basic Metabolic Panel:**
  - Sodium: 137mmol/L
  - Potassium: 3.3mmol/L
  - Chloride: 112mmol/L
  - Bicarbonate: Not provided
  - Blood Urea Nitrogen: 28mg/dL
  - Creatinine: 2.0mg/dL
  - Glucose: 236mg/dL

- **Liver Function Tests:**
  - Aspartate Aminotransferase (AST): 402U/L
  - Alanine Aminotransferase (ALT): 730U/L
  - Alkaline Phosphatase: 337U/L
  - Total Bilirubin: 1.9mg/dL

- **Pancreatic Enzymes:**
  - Lipase: 363U/L

- **Other Labs:**
  - Hemoglobin A1c: 10.3%
  - Beta-Hydroxybutyrate: 4.8mmol/L
  - Lactate: 2.9mmol/L
  - Anion Gap: 20
  - Venous Blood Gas:
    - pH: 7.14
    - pCO₂: 23mmHg

- **Urinalysis:**
  - Glucose: >1000mg/dL
  - Ketones: Large amount detected

- **Cardiac Enzymes:**
  - Troponin: Negative

**Additional Vital Signs:**

- Heart Rate increased to 119beats per minute
- Blood Pressure elevated to 163/91mmHg
- Respiratory Rate: 20breaths per minute
- Oxygen Saturation: 95% on room air

**Clinical Course:**
- The patient developed dark urine and worsening liver function tests, with transaminases exceeding 1000U/L during her hospital stay.

---

**Stage 3: Comprehensive Diagnostic Data**

**Laboratory Data:**

- **Complete Blood Count:**
  - Platelets decreased to 82×10³/μL

- **Coagulation Profile:**
  - International Normalized Ratio (INR): 1.7

- **Renal Function:**
  - Creatinine increased to 5.53mg/dL, later peaking at 6.84mg/dL
  - Bicarbonate decreased to 11mmol/L

- **Liver Function Tests:**
  - AST and ALT elevated above 1600U/L
  - Alkaline Phosphatase increased to 800+U/L
  - Total Bilirubin: Continued to rise

- **Pancreatic Enzymes:**
  - Lipase increased to >7000U/L

- **Iron Studies:**
  - Ferritin: >13,000ng/mL

- **Cardiac Enzymes:**
  - Troponin elevated to 0.41ng/mL

- **Metabolic Panel:**
  - Anion Gap: 18
  - Serum Osmolality: 302mOsm/kg
  - Lactate: 1.1mmol/L

- **Beta-Hydroxybutyrate:**
  - Decreased to 0.44mmol/L after treatment

- **Urinalysis:**
  - Presence of muddy brown casts

- **Toxicology and Infectious Workup:**
  - Negative for salicylates and urine toxicology screen
  - Negative hepatitis panel (A, B, C)
  - Negative HIV test
  - Cytomegalovirus (CMV), Epstein-Barr virus (EBV), and adenovirus PCR tests: Negative

- **Autoimmune Workup:**
  - Antinuclear Antibody (ANA): Low titer
  - Anti-smooth muscle antibody: Low titer
  - Serum ceruloplasmin and copper levels: Normal
  - Hemochromatosis gene mutation: H63D heterozygosity
  - Soluble interleukin-2 receptor (sIL-2R): Elevated

**Procedures:**

- **Paracentesis (Ascitic Fluid Analysis):**
  - No evidence of exudation
  - No signs of spontaneous bacterial peritonitis (SBP)

- **Dialysis:**
  - Initiated due to anuria and acute renal failure
  - Urinalysis findings suggestive of acute tubular necrosis
  - Improvement in liver function tests observed after dialysis

**Imaging Studies:**

- **Abdominal Ultrasound:**
  - Moderate ascites
  - Previous right hepatic lobe hemangioma noted in 2022 not visualized on current study
  - Bilateral non-obstructive nephrolithiasis
  - Spleen and gallbladder unremarkable

- **Doppler Ultrasound of Hepatic Vasculature:**
  - No evidence of thrombosis in hepatic or portal veins

- **Echocardiogram:**
  - Normal cardiac function
  - Small inferior vena cava (IVC) indicating low intravascular volume

- **Magnetic Resonance Imaging (MRI) of Abdomen:**
  - Moderate ascites and small bilateral pleural effusions
  - No evidence of biliary obstruction or cholecystitis
  - Mild to moderate wall thickening and edema of visualized small bowel loops

